194 related articles for article (PubMed ID: 22483307)
1. RNAi of cat-2, a putative tyrosine hydroxylase, increases alpha synuclein aggregation and associated effects in transgenic C. elegans.
Kaur S; Sammi SR; Jadiya P; Nazir A
CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):387-94. PubMed ID: 22483307
[TBL] [Abstract][Full Text] [Related]
2. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.
Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS
Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005
[TBL] [Abstract][Full Text] [Related]
3. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans.
Jadiya P; Fatima S; Baghel T; Mir SS; Nazir A
Mol Neurobiol; 2016 Nov; 53(9):6288-6300. PubMed ID: 26567108
[TBL] [Abstract][Full Text] [Related]
4. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
[TBL] [Abstract][Full Text] [Related]
5. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.
Gaeta AL; Nourse JB; Willicott K; McKay LE; Keogh CM; Peter K; Russell SN; Hamamichi S; Berkowitz LA; Caldwell KA; Caldwell GA
PLoS Genet; 2022 Aug; 18(8):e1010115. PubMed ID: 35984862
[TBL] [Abstract][Full Text] [Related]
6. Ida-1, the Caenorhabditis elegans orthologue of mammalian diabetes autoantigen IA-2, potentially acts as a common modulator between Parkinson's disease and Diabetes: role of Daf-2/Daf-16 insulin like signalling pathway.
Fatima S; Haque R; Jadiya P; Shamsuzzama ; Kumar L; Nazir A
PLoS One; 2014; 9(12):e113986. PubMed ID: 25469508
[TBL] [Abstract][Full Text] [Related]
7. Osmotic stress induced toxicity exacerbates Parkinson's associated effects via dysregulation of autophagy in transgenic C. elegans model.
Jadiya P; Mir SS; Nazir A
Cell Signal; 2018 May; 45():71-80. PubMed ID: 29410282
[TBL] [Abstract][Full Text] [Related]
8. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
[TBL] [Abstract][Full Text] [Related]
9. Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
Wei CC; Chang CH; Liao VH
Phytomedicine; 2017 Dec; 36():118-125. PubMed ID: 29157804
[TBL] [Abstract][Full Text] [Related]
10. Divergence in enzyme regulation between Caenorhabditis elegans and human tyrosine hydroxylase, the key enzyme in the synthesis of dopamine.
Calvo AC; Pey AL; Miranda-Vizuete A; Døskeland AP; Martinez A
Biochem J; 2011 Feb; 434(1):133-41. PubMed ID: 21087208
[TBL] [Abstract][Full Text] [Related]
11. 2-Butoxytetrahydrofuran, Isolated from
Promtang S; Sanguanphun T; Chalorak P; Pe LS; Niamnont N; Sobhon P; Meemon K
ACS Chem Neurosci; 2024 Jun; 15(11):2182-2197. PubMed ID: 38726817
[TBL] [Abstract][Full Text] [Related]
12. TDP-1/TDP-43 potentiates human α-Synuclein (HASN) neurodegeneration in Caenorhabditis elegans.
Shen L; Wang C; Chen L; Leung KL; Lo E; Lakso M; Wong G
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165876. PubMed ID: 32531261
[TBL] [Abstract][Full Text] [Related]
13. Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in
Chalorak P; Sanguanphun T; Limboonreung T; Meemon K
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443430
[TBL] [Abstract][Full Text] [Related]
14. Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
Fu RH; Wang YC; Chen CS; Tsai RT; Liu SP; Chang WL; Lin HL; Lu CH; Wei JR; Wang ZW; Shyu WC; Lin SZ
Neuropharmacology; 2014 Jul; 82():108-20. PubMed ID: 23973292
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
Chen KS; Menezes K; Rodgers JB; O'Hara DM; Tran N; Fujisawa K; Ishikura S; Khodaei S; Chau H; Cranston A; Kapadia M; Pawar G; Ping S; Krizus A; Lacoste A; Spangler S; Visanji NP; Marras C; Majbour NK; El-Agnaf OMA; Lozano AM; Culotti J; Suo S; Ryu WS; Kalia SK; Kalia LV
Mol Neurodegener; 2021 Nov; 16(1):77. PubMed ID: 34772429
[TBL] [Abstract][Full Text] [Related]
16. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease.
Johnson WM; Yao C; Siedlak SL; Wang W; Zhu X; Caldwell GA; Wilson-Delfosse AL; Mieyal JJ; Chen SG
Hum Mol Genet; 2015 Mar; 24(5):1322-35. PubMed ID: 25355420
[TBL] [Abstract][Full Text] [Related]
17. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.
Jadiya P; Chatterjee M; Sammi SR; Kaur S; Palit G; Nazir A
Biochem Biophys Res Commun; 2011 Sep; 413(2):306-10. PubMed ID: 21889494
[TBL] [Abstract][Full Text] [Related]
18. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
Calahorro F; Ruiz-Rubio M
Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
[TBL] [Abstract][Full Text] [Related]
19. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
[TBL] [Abstract][Full Text] [Related]
20. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans.
Kuwahara T; Koyama A; Koyama S; Yoshina S; Ren CH; Kato T; Mitani S; Iwatsubo T
Hum Mol Genet; 2008 Oct; 17(19):2997-3009. PubMed ID: 18617532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
